Jari Ratilainen

Title: Jari Ratilainen: Innovator in Cytoprotective Compounds

Introduction

Jari Ratilainen is a notable inventor based in Kulho, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as cytoprotectants. With a total of 7 patents to his name, Ratilainen's work has the potential to impact the treatment of various diseases.

Latest Patents

One of his latest patents is focused on the "Use of condensed benzo[B]thiazine derivatives as cytoprotectants." This invention relates to arylthiazine compounds and their use in treating or preventing diseases involving aberrant cellular lipid peroxidation in the central nervous system or periphery of the body. The patent also includes methods for preparing these compounds and pharmaceutical compositions containing them.

Another significant patent is for "Heteroarylamide derivatives having antiandrogenic properties." This invention describes novel heteroarylamide derivatives that possess antiandrogenic properties, along with their potential use as medicaments and the pharmaceutical compositions that include them.

Career Highlights

Throughout his career, Jari Ratilainen has worked with prominent companies in the pharmaceutical industry, including Orion Corporation and Aranda Pharma Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Jari has collaborated with notable professionals in his field, including Arja Karjalainen and Paavo Huhtala. These collaborations have likely enriched his research and development efforts.

Conclusion

Jari Ratilainen's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on cytoprotective compounds and antiandrogenic derivatives showcases the potential for advancements in medical treatments.